|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
US5270163A
(en)
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
|
US5683867A
(en)
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
|
US5705337A
(en)
|
1990-06-11 |
1998-01-06 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
|
US5496938A
(en)
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
|
US6344321B1
(en)
|
1990-06-11 |
2002-02-05 |
Gilead Sciences, Inc. |
Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
KR100272077B1
(ko)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
US5840867A
(en)
|
1991-02-21 |
1998-11-24 |
Gilead Sciences, Inc. |
Aptamer analogs specific for biomolecules
|
|
US5795965A
(en)
*
|
1991-04-25 |
1998-08-18 |
Chugai Seiyaku Kabushiki Kaisha |
Reshaped human to human interleukin-6 receptor
|
|
IE20030749A1
(en)
|
1991-05-03 |
2003-11-12 |
Indiana University Foundation |
Human notch and delta binding domains in torporythmic proteins, and methods based thereon
|
|
IL101728A
(en)
|
1991-05-03 |
2007-08-19 |
Univ Yale |
Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
|
|
US5582981A
(en)
|
1991-08-14 |
1996-12-10 |
Gilead Sciences, Inc. |
Method for identifying an oligonucleotide aptamer specific for a target
|
|
ATE408012T1
(de)
|
1991-12-02 |
2008-09-15 |
Medical Res Council |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
US20050112121A1
(en)
*
|
1992-04-30 |
2005-05-26 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
US5786158A
(en)
|
1992-04-30 |
1998-07-28 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
US5756291A
(en)
|
1992-08-21 |
1998-05-26 |
Gilead Sciences, Inc. |
Aptamers specific for biomolecules and methods of making
|
|
DE4425115A1
(de)
|
1994-07-15 |
1996-01-18 |
Boehringer Mannheim Gmbh |
Verfahren zur Modifizierung der Stabilität von Antikörpern
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
AU5752696A
(en)
*
|
1995-05-18 |
1996-11-29 |
Regents Of The University Of Michigan, The |
Dna binding antibodies
|
|
CA2229043C
(en)
|
1995-08-18 |
2016-06-07 |
Morphosys Gesellschaft Fur Proteinoptimierung Mbh |
Protein/(poly)peptide libraries
|
|
US7264963B1
(en)
|
1995-08-18 |
2007-09-04 |
Morphosys Ag |
Protein(poly)peptide libraries
|
|
DE19544393A1
(de)
|
1995-11-15 |
1997-05-22 |
Hoechst Schering Agrevo Gmbh |
Synergistische herbizide Mischungen
|
|
JP2000515364A
(ja)
|
1996-03-30 |
2000-11-21 |
サイエンス パーク ラフ ソチエタ ペル アツィオニ |
標識した活性化腫瘍特異的ｔ細胞の生産方法および腫瘍療法におけるそれらの使用
|
|
CA2256481A1
(en)
|
1996-05-31 |
1997-12-04 |
The National American Red Cross |
Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
|
|
FR2751986B1
(fr)
*
|
1996-08-01 |
1998-12-31 |
Inst Nat Sante Rech Med |
Gene implique dans le cadasil, methode de diagnostic et application therapeutique
|
|
CA2271248C
(en)
|
1996-11-07 |
2009-08-11 |
Jonathan Robert Lamb |
Use of a notch ligand in immunotherapy
|
|
EP0979281B1
(en)
|
1997-05-02 |
2005-07-20 |
Genentech, Inc. |
A method for making multispecific antibodies having heteromultimeric and common components
|
|
US6379925B1
(en)
*
|
1997-06-18 |
2002-04-30 |
The Trustees Of Columbia University In The City Of New York |
Angiogenic modulation by notch signal transduction
|
|
WO1998057621A1
(en)
|
1997-06-18 |
1998-12-23 |
The Trustees Of Columbia University In The City Ofnew York |
Angiogenic modulation by notch signal transduction
|
|
US6692919B1
(en)
|
1997-07-23 |
2004-02-17 |
Yale University |
Activated forms of notch and methods based thereon
|
|
US6004528A
(en)
|
1997-09-18 |
1999-12-21 |
Bergstein; Ivan |
Methods of cancer diagnosis and therapy targeted against the cancer stemline
|
|
US7361336B1
(en)
|
1997-09-18 |
2008-04-22 |
Ivan Bergstein |
Methods of cancer therapy targeted against a cancer stem line
|
|
EP1117778A2
(en)
|
1998-10-02 |
2001-07-25 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Methods and compositions for inducing differentiation and apoptosis in cells that overexpress the notch protein
|
|
US20030054360A1
(en)
|
1999-01-19 |
2003-03-20 |
Larry Gold |
Method and apparatus for the automated generation of nucleic acid ligands
|
|
US20030003572A1
(en)
|
1999-03-05 |
2003-01-02 |
David J. Anderson |
Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
|
|
US20020010320A1
(en)
|
1999-04-05 |
2002-01-24 |
James W. Fett |
Chemeric and humanized antibodies to angiogenin
|
|
WO2001002588A2
(en)
|
1999-07-02 |
2001-01-11 |
Morphosys Ag |
Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
|
|
US7605238B2
(en)
*
|
1999-08-24 |
2009-10-20 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
|
US20030031670A1
(en)
*
|
1999-11-08 |
2003-02-13 |
Jack R. Wands |
Diagnosis and treatment of malignant neoplasms
|
|
DE10031380A1
(de)
|
2000-06-28 |
2002-01-10 |
Merck Patent Gmbh |
Verfahren zur Übertragung von Alkyliden-Gruppen auf organischen Verbindungen
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US20080194022A1
(en)
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
|
AU2001288628A1
(en)
|
2000-08-31 |
2002-03-13 |
Loyola University Chicago |
Method and reagents for treatment of skin disorders by modulating the notch pathway
|
|
US6689744B2
(en)
*
|
2000-09-22 |
2004-02-10 |
Genentech, Inc. |
Notch receptor agonists and uses
|
|
AU2001296305B2
(en)
|
2000-09-26 |
2007-12-06 |
Duke University |
RNA aptamers and methods for identifying the same
|
|
JP2004517636A
(ja)
|
2000-10-02 |
2004-06-17 |
コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジー |
Ｂ型肝炎ウイルスの表面抗原ｓに対するヒト化抗体及びその製造方法
|
|
US7091323B2
(en)
*
|
2001-04-24 |
2006-08-15 |
Bayer Corporation |
Human TIMP-1 antibodies
|
|
US7356224B2
(en)
*
|
2001-07-03 |
2008-04-08 |
Brown University Research Foundation |
Method and apparatus for detecting multiple optical wave lengths
|
|
JP2005526701A
(ja)
|
2001-11-14 |
2005-09-08 |
ロランティス リミテッド |
内科療法
|
|
CA2469204A1
(en)
|
2001-12-07 |
2003-06-19 |
Regents Of The University Of Michigan |
Prospective identification and characterization of breast cancer stem cells
|
|
GB0201674D0
(en)
|
2002-01-25 |
2002-03-13 |
Lorantis Ltd |
Medical treatment
|
|
EP1481090A4
(en)
|
2002-02-15 |
2006-08-09 |
Somalogic Inc |
METHOD AND REAGENTS FOR DETECTING BINDING OF TARGET MOLECULES BY NUCLEIC ACID ELECTRODES
|
|
US20060275287A1
(en)
|
2002-06-21 |
2006-12-07 |
Brad St Croix |
Scroll compressor
|
|
DE10228103A1
(de)
|
2002-06-24 |
2004-01-15 |
Bayer Cropscience Ag |
Fungizide Wirkstoffkombinationen
|
|
WO2004041170A2
(en)
*
|
2002-11-01 |
2004-05-21 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20050124565A1
(en)
|
2002-11-21 |
2005-06-09 |
Diener John L. |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
|
AU2003295089A1
(en)
|
2002-12-06 |
2004-06-30 |
Singapore General Hospital Pte Ltd |
Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system
|
|
US20070178090A1
(en)
|
2003-04-01 |
2007-08-02 |
Genzyme Corporation |
Breast endothelial cell expression patterns
|
|
US7425328B2
(en)
|
2003-04-22 |
2008-09-16 |
Purdue Pharma L.P. |
Tissue factor antibodies and uses thereof
|
|
US7563748B2
(en)
|
2003-06-23 |
2009-07-21 |
Cognis Ip Management Gmbh |
Alcohol alkoxylate carriers for pesticide active ingredients
|
|
US7329742B2
(en)
|
2003-09-04 |
2008-02-12 |
The Regents Of The University Of California |
Aptamers and methods for their in vitro selection and uses thereof
|
|
GB0321805D0
(en)
|
2003-09-18 |
2003-10-15 |
Univ Wales Medicine |
Human tumour growth patterns
|
|
US7282203B2
(en)
|
2003-11-26 |
2007-10-16 |
Health Research, Inc. |
Use of NOTCH pathway interfering agents for treatment of plasma cell disorders
|
|
JP2007526455A
(ja)
|
2004-02-03 |
2007-09-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
癌を特徴付ける、制御する、診断する、および処置するための組成物ならびに方法
|
|
FR2867784B1
(fr)
|
2004-03-17 |
2006-06-09 |
Commissariat Energie Atomique |
Aptameres selectionnes a partir de cellules vivantes tumorales et leurs applications
|
|
EP1730531B1
(en)
|
2004-03-24 |
2014-01-15 |
Technion Research and Development Foundation, Limited |
Electrode
|
|
US20050239134A1
(en)
|
2004-04-21 |
2005-10-27 |
Board Of Regents, The University Of Texas System |
Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein
|
|
WO2005111072A2
(en)
*
|
2004-04-29 |
2005-11-24 |
The Trustees Of Columbia University In The City Of New York |
Notch-based fusion proteins and uses thereof
|
|
RU2346996C2
(ru)
|
2004-06-29 |
2009-02-20 |
ЮРОПИЭН НИКЕЛЬ ПиЭлСи |
Усовершенствованное выщелачивание основных металлов
|
|
US20070077245A1
(en)
|
2004-08-04 |
2007-04-05 |
The Brigham And Women's Hospital, Inc. |
NOTCH mutations leading to increased receptor signaling
|
|
GB0421838D0
(en)
|
2004-09-30 |
2004-11-03 |
Congenia S R L |
Cancer markers
|
|
WO2006053063A2
(en)
|
2004-11-05 |
2006-05-18 |
The Regents Of The University Of California |
Notch-1 assay to detect neurodegenerative diseases
|
|
RU2392961C2
(ru)
*
|
2004-11-10 |
2010-06-27 |
Хубрехт Лабораториум |
Лечение аденомы и/или аденокарциномы кишечника с помощью ингибирования активации пути notch
|
|
CA2629330C
(en)
|
2004-11-12 |
2018-05-22 |
Cambridge University Technical Services Ltd. |
Methods and means related to cancer stem cells
|
|
JP2008535853A
(ja)
|
2005-04-07 |
2008-09-04 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド |
癌関連遺伝子
|
|
WO2007000020A1
(en)
|
2005-06-29 |
2007-01-04 |
Compumedics Limited |
Sensor assembly with conductive bridge
|
|
AU2006308847C1
(en)
|
2005-10-31 |
2012-05-10 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for treating and diagnosing cancer
|
|
US20090305310A1
(en)
|
2005-11-22 |
2009-12-10 |
University Of Vermont And State Agricultural College |
Methods for Determining Notch Signaling and Uses Thereof
|
|
DK1962895T3
(da)
|
2005-12-16 |
2013-03-04 |
Regeneron Pharma |
TERAPEUTISK ANVENDELSE AF EN Dll4-ANTAGONIST OG EN VEGF-HÆMMER TIL HÆMNING AF TUMORVÆKST
|
|
WO2007075915A2
(en)
|
2005-12-22 |
2007-07-05 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies against orthopoxviruses
|
|
AR059922A1
(es)
|
2006-04-01 |
2008-05-07 |
Galaxy Biotech Llc |
Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos
|
|
US20080241150A1
(en)
|
2006-05-15 |
2008-10-02 |
The Brigham And Women's Hospital, Inc. |
Functional negative regulatory domain sequences from human NOTCH1 and 2 and isolated LNR domains from human NOTCH1
|
|
CA2654000A1
(en)
|
2006-06-06 |
2008-05-22 |
Genentech, Inc. |
Anti-dll4 antibodies and methods using same
|
|
US20080014196A1
(en)
|
2006-06-06 |
2008-01-17 |
Genentech, Inc. |
Compositions and methods for modulating vascular development
|
|
PL2032166T3
(pl)
*
|
2006-06-13 |
2013-09-30 |
Oncomed Pharm Inc |
Kompozycje i sposoby diagnozowania i leczenia nowotworów
|
|
TW200801513A
(en)
|
2006-06-29 |
2008-01-01 |
Fermiscan Australia Pty Ltd |
Improved process
|
|
WO2008050525A1
(en)
|
2006-09-29 |
2008-05-02 |
Konica Minolta Opto, Inc. |
Retardation film
|
|
US7750124B2
(en)
|
2006-09-29 |
2010-07-06 |
Oncomed Pharmaceuticals, Inc. |
Anti-human DLL4 antibodies and compositions
|
|
CL2007002989A1
(es)
|
2006-10-19 |
2008-05-16 |
Genentech Inc |
Anticuerpos anti-notch3; acido nucleico que los codifica; vector y celula que lo comprende; metodo de produccion; y su uso para el diagnostico de enfermedades relacionadas con notch3.
|
|
AR063494A1
(es)
|
2006-10-19 |
2009-01-28 |
Genentech Inc |
Anticuerpos agonistas anti notch3 y su uso en el tratamiento de las enfermedades relacionadas con el gen notch3
|
|
WO2008048680A2
(en)
*
|
2006-10-19 |
2008-04-24 |
Maine Medical Center Research Institute |
Notch 2 signaling as a breast cancer suppressor pathway
|
|
US20100068688A1
(en)
|
2006-11-06 |
2010-03-18 |
Howard Shapiro |
Management of teaching processes for individualized instruction in a multistudent environment
|
|
NO347649B1
(no)
|
2006-12-14 |
2024-02-12 |
Regeneron Pharma |
Humant antistoff eller antistoff fragment som spesifikt binder human deltaliknende ligand 4 (hDII4), nukleinsyremolekyl som koder for slike og vektor og vert-vektorsystemer, samt fremgangsmåte for fremstilling, sammensetning og anvendelse.
|
|
WO2008076960A2
(en)
|
2006-12-18 |
2008-06-26 |
Genentech, Inc. |
Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
|
|
EP2120996A2
(en)
|
2006-12-20 |
2009-11-25 |
Vasgene Therapeutics, Inc. |
Methods for using and identifying modulators of delta-like 4
|
|
JP5618544B2
(ja)
|
2007-01-24 |
2014-11-05 |
オンコメッドファーマシューティカルズ インコーポレイテッド |
癌の診断および処置のための組成物および方法
|
|
US20100119526A1
(en)
|
2007-01-26 |
2010-05-13 |
Bioinvent International Ab |
DLL4 Signaling Inhibitors and Uses Thereof
|
|
US20090208491A1
(en)
|
2007-02-14 |
2009-08-20 |
Austin Gurney |
Compositions and Methods for Diagnosing and Treating Cancer
|
|
US20100099090A1
(en)
*
|
2007-03-05 |
2010-04-22 |
Bristol-Mayers Squibb Company |
Biomarkers and methods for determining sensitivity to ctla-4 antagonists
|
|
EP2134356A2
(en)
|
2007-03-05 |
2009-12-23 |
Board of Regents, The University of Texas System |
Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy
|
|
PE20090321A1
(es)
*
|
2007-06-04 |
2009-04-20 |
Genentech Inc |
Anticuerpos anti-notch1 nrr, metodo de preparacion y composicion farmaceutica
|
|
MY150531A
(en)
|
2007-07-16 |
2014-01-30 |
Genentech Inc |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
|
CA2697262A1
(en)
|
2007-08-23 |
2009-02-26 |
The Trustees Of Columbia University In The City Of New York |
Compositions of humanized notch fusion proteins and methods of treatment
|
|
US20110166028A1
(en)
|
2007-08-28 |
2011-07-07 |
Donald Bergstrom |
Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancers
|
|
US7807630B2
(en)
|
2007-09-14 |
2010-10-05 |
Vanderbilt University |
Targeting of Notch3 receptor function for cancer therapy
|
|
WO2009035522A1
(en)
|
2007-09-14 |
2009-03-19 |
Albert Einstein College Of Medicine Of Yeshiva University |
Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal disease
|
|
US20120082659A1
(en)
|
2007-10-02 |
2012-04-05 |
Hartmut Land |
Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
|
|
US8119366B2
(en)
|
2007-10-05 |
2012-02-21 |
Trojan Technologies, Ltd. |
Antennapedia-dominant negative mastermind-like construct
|
|
WO2009124931A2
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Amino acid sequences directed against the notch pathways and uses thereof
|
|
WO2010000020A1
(en)
|
2008-06-30 |
2010-01-07 |
Cathrx Ltd |
A catheter
|
|
US9132189B2
(en)
|
2008-07-08 |
2015-09-15 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
US8834875B2
(en)
|
2010-01-13 |
2014-09-16 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
CN102316897B
(zh)
|
2008-07-08 |
2014-11-05 |
昂考梅德药品有限公司 |
Notch结合剂和拮抗剂及其应用方法
|
|
ES2541726T3
(es)
|
2008-10-01 |
2015-07-23 |
F. Hoffmann-La Roche Ag |
Anticuerpos anti-Notch2 y métodos de uso
|
|
CA2760999A1
(en)
|
2009-03-13 |
2010-09-16 |
Mariana Barboza |
Prebiotic oligosaccharides
|
|
PH12012500574A1
(en)
|
2009-09-30 |
2012-10-22 |
Genentech Inc |
Notch1-antagonist-resistant cancer(s) using notch3 antagonists
|
|
DE102009047243A1
(de)
|
2009-11-27 |
2011-06-01 |
Orgentec Diagnostika Gmbh |
Monospezifische Polypeptidreagenzien
|
|
US8551715B2
(en)
|
2010-02-12 |
2013-10-08 |
Oncomed Pharmaceuticals, Inc. |
Methods for identifying and isolating cells expressing a polypeptide
|
|
JP5450221B2
(ja)
|
2010-04-14 |
2014-03-26 |
株式会社神戸製鋼所 |
高電流密度ガスシールドアーク溶接方法
|
|
AU2011248083B2
(en)
|
2010-05-04 |
2015-09-10 |
Five Prime Therapeutics, Inc. |
Antibodies that bind CSF1R
|
|
WO2012003472A1
(en)
|
2010-07-02 |
2012-01-05 |
Aveo Pharmaceuticals, Inc. |
Anti-notch1 antibodies
|
|
HUE065915T2
(hu)
|
2011-03-11 |
2024-06-28 |
Beth Israel Deaconess Medical Ct Inc |
Anti-CD40 antitestek és alkalmazásaik
|
|
WO2013074596A1
(en)
|
2011-11-16 |
2013-05-23 |
Oncomed Pharmaceuticals, Inc. |
Human notch receptor mutations and their use
|
|
WO2013173542A1
(en)
|
2012-05-16 |
2013-11-21 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating cancer with notch2/3 antibodies
|
|
EP2892524B1
(en)
|
2012-09-04 |
2020-11-25 |
Eleison Pharmaceuticals, LLC |
Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
|
|
EP2897643A4
(en)
|
2012-09-21 |
2016-04-20 |
Oncomed Pharm Inc |
METHOD FOR THE TREATMENT OF MOLECULAR BLOOD DISEASES WITH NOTCH1 ANTIBODIES
|
|
BR112015010436A2
(pt)
|
2012-11-07 |
2017-08-22 |
Pfizer |
Anticorpos anti-notch3 e conjugados anticorpo-fármaco
|
|
HK1211322A1
(en)
|
2013-03-15 |
2016-05-20 |
昂考梅德药品有限公司 |
Methods of treating pancreatic cancer
|
|
EP3113799A1
(en)
|
2014-03-07 |
2017-01-11 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating cancer with notch1 antibodies
|
|
US20170023576A1
(en)
|
2014-04-04 |
2017-01-26 |
Oncomed Pharmaceuticals, Inc. |
Notch3 antibodies and uses thereof
|